Skip to main content

. 1971 Feb;47(544):137–138. doi: 10.1136/pgmj.47.544.137

A massive lipoma in a patient receiving chlorpropamide therapy.

PMCID: PMC2467163 PMID: 5572529

Images in this article

Fig. 1
on p.137

Fig. 2
on p.138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

LOUBATIERES A. The mechanism of action of the hypoglycemic sulfonamides; a concept based on investigations in animals and in man. Diabetes. 1957 Sep-Oct;6(5):408–417. doi: 10.2337/diab.6.5.408. [DOI] [PubMed] [Google Scholar]
Madsen J. Extrapancreatic and intrapancreatic action of antidiabetic sulphonylureas. A review. Acta Med Scand Suppl. 1967;476:109–122. doi: 10.1111/j.0954-6820.1967.tb12690.x. [DOI] [PubMed] [Google Scholar]
Samols E., Tyler J. M., Mialhe P. Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas. Lancet. 1969 Jan 25;1(7587):174–176. doi: 10.1016/s0140-6736(69)91189-1. [DOI] [PubMed] [Google Scholar]
Tranquada R. E. Subcutaneous lipomas at sites of insulin injection. Report of a case. Diabetes. 1966 Nov;15(11):807–809. doi: 10.2337/diab.15.11.807. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES